Develops anti-cancer therapeutics for patients with high unmet medical need.
Dec 2025Revenue $320K/yrExpenses $12.9M/yr
No trendCash runway ≈ 1.2 years from Jun 2026
Figures by year
When will Allarity Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $320K and expenses $12.9M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $320K | $12.9M | −$12.6M |
| Dec 2024 | $0.00 | $27.2M | −$27.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.